Genfit S.A. (GNFT)

3.3800 +0.0200 (+0.60%) At close: 04:00PM EDT

Genfit S.A.

Parc EurasantE
885, avenue EugEne AvinEe
Loos 59120
France
33 3 20 16 40 00
https://www.genfit.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jean-Francois Mouney	Co-Founder & Chairman	252.14k	N/A	1955
Mr. M. Pascal Prigent	Chief Exec. Officer	430.29k	N/A	1968
Prof. Bart Staels	Co-Founder & Chairman of the Scientific Advisory Board	N/A	N/A	1963
Mr. Thomas Baetz	Chief Financial Officer	N/A	N/A	1974
Mr. Pascal Caisey	Chief Operating Officer	N/A	N/A	1969
Dr. Dean W. Hum Ph.D.	Chief Scientific Officer	N/A	N/A	1962
Mr. Laurent Lannoo	Corp. Sec. & Director of Legal Affairs	N/A	N/A	1970
Ms. Stefanie Magner	Chief Compliance Officer & VP of International Legal Affairs	N/A	N/A	1981
Ms. Emilie Desodt	Vice-Pres of HR	N/A	N/A	N/A
Mr. Jean-Christophe Marcoux	Chief Strategy Officer	N/A	N/A	1977

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Corporate governance

Genfit S.A.’s ISS governance QualityScore as of 1 May 2022 is 9. The pillar scores are Audit: 9; Board: 8; Shareholder rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.